Reference
Iovino A, et al. Acute leukocytosis during alemtuzumab treatment in patients with active relapsing-remitting multiple sclerosis. Multiple Sclerosis and Related Disorders 28: 98-100, 2019. Available from: URL: http://doi.org/10.1016/j.msard.2018.12.024 - Italy
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 1737, 21 (2019). https://doi.org/10.1007/s40278-019-57116-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-57116-9